Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

Conditions:   Coronary Heart Disease;   Diastolic Dysfunction Intervention:   Drug: Trimetazidine Sponsor:   China National Center for Cardiovascular Diseases Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials